BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12208865)

  • 1. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis.
    Bhoumik A; Huang TG; Ivanov V; Gangi L; Qiao RF; Woo SL; Chen SH; Ronai Z
    J Clin Invest; 2002 Sep; 110(5):643-50. PubMed ID: 12208865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of melanoma growth and metastasis by ATF2-derived peptides.
    Bhoumik A; Gangi L; Ronai Z
    Cancer Res; 2004 Nov; 64(22):8222-30. PubMed ID: 15548688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity.
    Bhoumik A; Jones N; Ronai Z
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4222-7. PubMed ID: 15010535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage.
    Cho SG; Bhoumik A; Broday L; Ivanov V; Rosenstein B; Ronai Z
    Mol Cell Biol; 2001 Dec; 21(24):8398-413. PubMed ID: 11713276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATF2 confers radiation resistance to human melanoma cells.
    Ronai Z; Yang YM; Fuchs SY; Adler V; Sardana M; Herlyn M
    Oncogene; 1998 Jan; 16(4):523-31. PubMed ID: 9484842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
    Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
    Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment.
    Bhoumik A; Ivanov V; Ronai Z
    Clin Cancer Res; 2001 Feb; 7(2):331-42. PubMed ID: 11234888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death receptors and melanoma resistance to apoptosis.
    Ivanov VN; Bhoumik A; Ronai Z
    Oncogene; 2003 May; 22(20):3152-61. PubMed ID: 12789291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death.
    Buschmann T; Yin Z; Bhoumik A; Ronai Z
    J Biol Chem; 2000 Jun; 275(22):16590-6. PubMed ID: 10748185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.
    Abbas S; Bhoumik A; Dahl R; Vasile S; Krajewski S; Cosford ND; Ronai ZA
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6769-78. PubMed ID: 18006779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient increase in anti-p-ATF2 immunoreactivity in the late secretion ameloblasts apical to the transition zone of rat incisors.
    Nishikawa S
    Anat Sci Int; 2004 Jun; 79(2):87-94. PubMed ID: 15218628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4.
    Shimizu M; Nomura Y; Suzuki H; Ichikawa E; Takeuchi A; Suzuki M; Nakamura T; Nakajima T; Oda K
    Exp Cell Res; 1998 Feb; 239(1):93-103. PubMed ID: 9511728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer.
    Choi CY; Choi BH; Park GT; Rho HM
    J Biol Chem; 1997 Jul; 272(27):16934-9. PubMed ID: 9202004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways.
    Min W; Pober JS
    J Immunol; 1997 Oct; 159(7):3508-18. PubMed ID: 9317150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination and degradation of ATF2 are dimerization dependent.
    Fuchs SY; Ronai Z
    Mol Cell Biol; 1999 May; 19(5):3289-98. PubMed ID: 10207054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of tumor necrosis factor alpha expression by activating transcription factor 2 increases UVC-induced apoptosis of late-stage melanoma cells.
    Ivanov VN; Ronai Z
    J Biol Chem; 1999 May; 274(20):14079-89. PubMed ID: 10318823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GTP cyclohydrolase I gene transcription by basic region leucine zipper transcription factors.
    Al Sarraj J; Vinson C; Han J; Thiel G
    J Cell Biochem; 2005 Dec; 96(5):1003-20. PubMed ID: 16149046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
    Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
    Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2).
    Steinmüller L; Thiel G
    Biol Chem; 2003 Apr; 384(4):667-72. PubMed ID: 12751796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2.
    Miethe J; Schwartz C; Wottrich K; Wenning D; Klempnauer KH
    Oncogene; 2001 Dec; 20(56):8116-24. PubMed ID: 11781825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.